Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Harmony Biosciences (Nasdaq: HRMY) has scheduled its fourth quarter and full year 2024 financial results announcement for February 25, 2025, before U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.
Participants can join the call by dialing 800-445-7795 (domestic) or 785-424-1699 (international) using passcode HRMYQ424. The company recommends joining the call at least 10 minutes early. Both live and replay versions of the webcast will be available on Harmony's investor relations website.
Harmony Biosciences (Nasdaq: HRMY) ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per 25 febbraio 2025, prima dell'apertura dei mercati finanziari statunitensi. L'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 a.m. ET nello stesso giorno per discutere i risultati.
I partecipanti possono unirsi alla chiamata componendo il numero 800-445-7795 (nazionale) o 785-424-1699 (internazionale) utilizzando il codice di accesso HRMYQ424. L'azienda consiglia di unirsi alla chiamata almeno 10 minuti prima. Saranno disponibili sia la versione in diretta che quella registrata del webcast sul sito web delle relazioni con gli investitori di Harmony.
Harmony Biosciences (Nasdaq: HRMY) ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para 25 de febrero de 2025, antes de la apertura de los mercados financieros en EE. UU. La empresa llevará a cabo una llamada de conferencia y un webcast a las 8:30 a.m. ET el mismo día para discutir los resultados.
Los participantes pueden unirse a la llamada marcando el 800-445-7795 (nacional) o el 785-424-1699 (internacional) utilizando el código de acceso HRMYQ424. La empresa recomienda unirse a la llamada al menos 10 minutos antes. Estarán disponibles tanto la versión en vivo como la grabada del webcast en el sitio web de relaciones con inversores de Harmony.
하모니 바이오사이언스(Harmony Biosciences)(Nasdaq: HRMY)는 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 25일 미국 금융 시장 개장 전에 예정하고 있습니다. 회사는 같은 날 오전 8시 30분 ET에 결과를 논의하기 위한 전화 회의 및 웹캐스트를 개최할 예정입니다.
참가자는 800-445-7795(국내) 또는 785-424-1699(국제)로 전화하여 HRMYQ424 비밀번호를 사용하여 통화에 참여할 수 있습니다. 회사는 최소 10분 전에 통화에 참여할 것을 권장합니다. 하모니의 투자자 관계 웹사이트에서 실시간 및 재생 버전의 웹캐스트를 이용할 수 있습니다.
Harmony Biosciences (Nasdaq: HRMY) a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le 25 février 2025, avant l'ouverture des marchés financiers américains. L'entreprise organisera une conférence téléphonique et un webcast le même jour à 8h30 ET pour discuter des résultats.
Les participants peuvent rejoindre l'appel en composant le 800-445-7795 (national) ou le 785-424-1699 (international) en utilisant le code d'accès HRMYQ424. L'entreprise recommande de se connecter au moins 10 minutes à l'avance. Des versions en direct et enregistrées du webcast seront disponibles sur le site web des relations investisseurs de Harmony.
Harmony Biosciences (Nasdaq: HRMY) hat die Bekanntgabe der finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf den 25. Februar 2025 vor der Eröffnung der US-Finanzmärkte terminiert. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen.
Teilnehmer können sich über die Nummer 800-445-7795 (national) oder 785-424-1699 (international) mit dem Zugangscode HRMYQ424 in die Konferenz einwählen. Das Unternehmen empfiehlt, sich mindestens 10 Minuten früher einzuwählen. Sowohl die Live- als auch die Wiederholungsversion des Webcasts werden auf der Investor Relations-Website von Harmony verfügbar sein.
- None.
- None.
To participate in the call, please dial 800-445-7795 (domestic) or 785-424-1699 (international), and reference passcode HRMYQ424. It is recommended that you dial in at least 10 minutes prior to the call.
The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218064471/en/
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
Source: Harmony Biosciences Holdings, Inc.
FAQ
When will Harmony Biosciences (HRMY) release Q4 and FY 2024 earnings?
What time is Harmony Biosciences (HRMY) Q4 2024 earnings call?
How can investors access HRMY's Q4 2024 earnings call?
Where can I find the replay of HRMY's Q4 2024 earnings webcast?
